Floatz logo

SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN)

Breast Neoplasm

Evgen PharmaSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

177 Active assets in the Breast Neoplasm cohort.

Asset / SponsorPhaseRating
Letrozole
Fujian Cancer Hospital
Phase 4BB
EXEMESTANE
Fujian Cancer Hospital
Phase 4BB
Cyclophosphamide
Merck Sharp & Dohme LLC
Phase 4BB
Inno-206
Merck Sharp & Dohme LLC
Phase 4BB
Docetaxel
Universitas Airlangga
Phase 4BB

View all 50 →

Same molecule, other indications

SFX-01 (SULFORAPHANE STABILIZED WITH .ALPHA. CYCLODEXTRIN) is also rated in:

HIV infectious diseaseDormant
B
Indicative ·
62 / 100
View asset →
prostate cancerDormant
B
Indicative ·
57 / 100
View asset →
schizoaffective disorderDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →